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The riboflavin-binding protein isolated from sera of oestrogen-treated male chicks as
well as that synthesized and secreted in vitro by the chicken liver have the same molecular
size as that of the egg-yolk protein. Functionally the serum and yolk proteins are similar.
This is in contrast with the hormone-induced synthesis, secretion and deposition of
phosvitin and lipovitellin in the ovary.
In oviparous species, liver is the exclusive site of
biosynthesis and secretion of yolk proteins (Heald &
McLachlan, 1963; Tata, 1976), and oestrogen can
specifically induce these proteins in the adult male and
immnature animals of either sex (Tata, 1976; Gruber
et al., 1976). Both in amphibia and the domestic fowl,
the major yolk proteins, namely phosvitin and
lipovitellin, are elaborated only as parts of a macro-
molecular precursor, namely vitellogenin, which is
transported through the blood to be split into con-
stituent molecules in the course of or after uptake by
the ovary (Deeley et al., 1975; Gruber et al., 1976).
It is not known, however, whether this type of
precursor processing is obligatory in the elaboration
of other yolk proteins.
Riboflavin-binding protein of hen's egg, a unique
phosphoglycoprotein of molecular weight similar to
that of phosvitin (approx. 34000), is a minor yolk
constituent also inducible specifically by oestrogen
(Murthy & Adiga, 1977a). The kinetics of its
induction in oestrogen-treated male chicks follow a
pattern very reminiscent of those of vitellogenin,
similarity extending from initial lag phase, through
the memory effect during secondary stimulation
(Murthy & Adiga, 1977c) to the half-life in the
circulation (Murthy & Adiga, 1977b). In the present
communication, we show that riboflavin-binding
protein, unlike the major yolk proteins, is secreted
by the chicken liver and circulates in the blood in a
form indistinguishable functionally and with respect
to molecular size from that present in the yolk.
Materials and Methods
L-[3H]Lysine monohydrochloride (sp. radioactivity
1.6Ci/mmol), L-[3H]serine (sp. radioactivity 5.4Ci/
mmol) and L-[3H]tyrosine (sp. radioactivity 5.6Ci/
mmol) were obtained from the Bhabha Atomic Re-
search Centre, Trombay, Bombay, India. Riboflavin-
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binding protein was isolated in a homogeneous form
from egg white (Murthy & Adiga, 1977a) and egg
yolk (Ostrowski et al., 1962), and a monospecific
antibody against the egg-white riboflavin-binding
protein was raised in rabbits as described elsewhere
(Murthy et al., 1976). Florisil was obtained through
Sigma Chemical Co., St. Louis, MO, U.S.A. The
sources of other biochemicals are detailed elsewhere
(Murthy & Adiga, 1977a).
Isolation ofriboflavin-binding proteinfrom the serum
The isolation procedure was essentially the same
as described for egg-white riboflavin-binding protein
(Murthy & Adiga, 1977a) with some minor modifi-
cations. Pooled serum from 3-month-old White
Leghorn male chicks chronically stimulated with
oestradiol-1711 (10mg/kg body wt. in propane-1,2-
diol, intramuscularly daily for 4 days) was dialysed
against 0.1 M-sodium acetate buffer, pH4.6, and
fractionated on a DEAE-cellulose column (2cmx
34cm) with 0.5M-NaCl/0.1 M-sodium acetate buffer
(pH4.6) as eluent. Further purification was achieved
by gel filtration on Sephadex G-100. For more de-
tails, see the legend to Fig. 1.
Separation oftheflavinfrom the apoprotein
The pH of the protein solution was adjusted to 3.0
and filtered through a column (1.5cmx20cm)
of Sephadex G-25 with 0.1M-sodium citrate buffer,
pH3.0, as eluent, to separate the yellow flavin from
the apoprotein (Ostrowski et al., 1962).
Purification and identification oftheflavin
The flavin fraction was purified by adsorption on a
Florisil column (1.5cmx20cm) and elution with
aq. 10% (v/v) pyridine (Kumar et al., 1968). Pyridine
was removed in vacuo and the flavin chromatographed
on paper (Giri &Krishnaswamy, 1956), with butanol/
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acetic acid/water (4:1:5, by vol.) as solvent and
riboflavin, FMN and FAD as standard markers.
Flavin-apoprotein interaction
This was monitored spectrofluorimetrically by
measuring the quenching of flavin fluorescence
(Murthy et al., 1976).
Polyacrylamide-gel electrophoresis
Electrophoresis on analytical polyacrylamide gels
(7.5%, w/v) was performed as described by Davis
(1964). The gels were stained for protein (Murthy &
Adiga, 1977a) and for glycoprotein (Zacharius et al.,
1969). Labelled riboflavin-binding-protein-antibody
complex was analysed by sodium dodecyl sulphate/
polyacrylamide-gel electrophoresis by the procedure
of Palmiter et al. (1971). After electrophoresis, the
gels were sliced into 2mm-thick discs and individual
discs were digested and counted for radioactivity
(Young & Fullhorst, 1965).
Labelling of riboflavin-binding protein with 3H-
labelled amino acids in vitro
Livers quickly excised from chicks 24h after a
single injection of oestradiol-17f6 (0mg/kg body wt.)
were cut into 1 mm-thick slices and approx. 3 g of the
tissue was incubated with shaking at 37°C for 4h in
Eagle's essential minimal medium (pH 7.4, 9 ml),
devoid of unlabelled tyrosine, lysine and serine,
but supplemented with streptomycin (100,ug/ml)
pencillin (100,ug/ml), NaHCO3 (2.2mg/ml) and the
three radioactive amino acids (10,Ci each/ml). After
incubation, the medium was separated from the
tissue and analysed for secreted labelled riboflavin-
binding protein. Washed tissue slices were homo-
genized in 10vol. of0.01 M-phosphate-buffered saline,
pH7.4 (0.9y% NaCl in 0.01 M-sodium/potassium
phosphate buffer, pH 7.4), and the homogenates clari-
fied by centrifugation at 140000g for 60min. The
cytosolic supernatant was analysed for incorporation
of 3H-labelled amino acid into riboflavin-binding
protein after immunoprecipitation and sodium
dcodecyl sulphate/polyacryl amide-gel electrophoresis.
Immunoprecipitation of labelled riboflavin-binding
protein
To 0.5 ml portions of the tissue homogenate or the
incubation media was added 50,pg of pure riboflavin-
binding protein as carrier followed by an excess
(0.2 ml) of the monospecific antibody to riboflavin-
binding protein and sodium deoxycholate (Luskey
et al., 1974) in phosphate-buffered saline to a final
concentration of 1% (total volume 1.5 ml). After
incubation at 370C for 1 h and overnight at 4°C, the
immunoprecipitate was washed by centrifugation
three times at 2000g for 20min with cold phosphate-
buffered saline and subjected to sodium dodecyl
sulphate/polyacrylamide-gel electrophoresis as des-
cribed above.
Results and Discussion
Implicit in earlier studies ofthe mode ofelaboration
of several polypeptide hormones (Lernmark et al.,
1976) and yolk proteins (Deeley et al., 1975) is the
basic assumption that the precursors of these proteins
share immunological characteristics with their
respective products. In fact, the conclusive proof that
vitellogenin is the biosynthetic and circulating
macromolecular precursor for phosvitin and lipo-
vitellin in amphibia (Berridge & Lane, 1976) and in
chicks (Deeley et al., 1975) stems from experiments
based on this premise. With this consideration in view,
we have ascertained by double-diffusion analysis on
agar (Murthy et al., 1976) and using the monospecific
antibody to riboflavin-binding protein that there is
only one immunoactive species in the sera of oestro-
gen-treated chicks. This sensitive test was routinely
used to monitor the progress of fractionation and to
ensure that no cross-reacting material is lost during
the process. Since riboflavin-binding protein is a
minor yolk constituent as well as a serum constituent,
its isolation in significant amounts was considered
necessary for its physicochemical and functional
characterization. Advantage was taken of several
known properties of egg riboflavin-binding proteins
(Murthy & Adiga, 1977a; Ostrowski et al., 1962),
and the pooled sera were processed at 0-40C to
minimize proteolytic activity. Although dialysis
against 0.1 M-acetate buffer facilitated removal by
precipitation of considerable amounts of extraneous
serum proteins, during chromatography on DEAE-
cellulose more than 80% of the remaining materials
were washed off the column. Subsequent elution with
0.5M-NaCl resulted in a protein fraction (Fig. la)
accounting for over 95% of riboflavin-binding
protein, as revealed by a quantitative immunopre-
cipitation procedure. Dialysis of this turbid yellow
fraction against water led to further precipitation of
nearly 85 % of the other inactive proteins, which were
removed by centrifugation (100OOg for 10min).
The clear yellow supernatant was shown by disc gel
electrophoresis to contain two major glycoproteins
in almost equal proportions, one of which had
a mobility identical with that of purified yolk ribo-
flavin-binding protein.
Further purification was sought by gel filtration
on a Sephadex G-100 column (Fig. lb). Nearly 50%
of the material was devoid of immunological cross-
reactivity and was of apparently higher molecular
weight (Fig. lb, peak A). The protein fraction sub-
sequently eluted with an absorbance at both 280nm
and 455nm (Fig. lb, peak B) represented purified
riboflavin-binding protein. From 44ml of serum, a
yield of 5mg of purified protein was obtained.
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Fig. 1. Elution ofriboflavin-binding protein from sera ofoestrogen-treated chickenfrom a DEAE-cellulose column (a)followed
by elutionfrom a Sephadex G-100 column (b)
(a) Chicken sera (44ml), dialysed against two changes of 0.1 M-acetate buffer, pH4.6, and clarified, were loaded on a
DEAE-cellulose column (2cmx34cm) pre-equilibrated with 0.1 M-acetate buffer, pH4.6. The column was washed
with the starting buffer (100ml) until the effluent was free of A280-absorbing material and eluted with 0.5M-NaCl;
fractions of volume 2ml were collected. Fraction nos. 10-30 were pooled, dialysed against water, clarified by centri-
fugation and concentrated (crude riboflavin-binding protein). (b) Crude riboflavin-binding protein (10mg, 1 ml) eluted
from DEAE-cellulose was loaded on a Sephadex G-100 column (2cmx63cm) pre-equilibrated and eluted with
0.5M-NaCl in 0.02M-phosphate buffer, pH7.4. Fractions of volume 2ml were collected.
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Fig. 2. Fluorimetric titration of the serum apo-(riboflavin-
binding protein) with riboflavin
Fluorescence of riboflavin was excited at 370nm and
analysed at 520nm. The amount of riboflavin at the
indicated final concentration was added to 3.5ml of
the apoprotein solution (38pg) in O.1M-phosphate
buffer, pH7.0. 0, Buffer alone; *, apoprotein in the
buffer. Fluorescence is given relative to standard
riboflavin.
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The purified protein on sodium dodecyl sulphate/
polyacrylamide-gel electrophoresis exhibited a sharp
major band with a mobility identical with that ofyolk
riboflavin-binding protein (Mr36000) and a minor
(<5%) diffuse band of slightly higher molecular
weight. Co-electrophoresis could not separate this
major protein band from the yolk riboflavin-binding
protein.
To study the interaction with riboflavin, the
apoprotein was resolved from the flavin by gel
filtration on a Sephadex G-25 column as described
above. The flavin purified through a Florisil column
was identified as exclusively riboflavin by paper
chromatography. The apoprotein, when titrated
fluorimetrically against increasing amounts of
riboflavin, completely quenched the flavin fluores-
cence and gave a sharp end point (Fig. 2) as for
egg-white and egg-yolk riboflavin-binding protein
(Rhodes et al., 1959; Ostrowski et al., 1968). Since the
molecular weight of the serum riboflavin-binding
protein was equal to that of yolk riboflavin-binding
protein (36000), it could be calculated that the
apoprotein-flavin interaction occurred in 1 :1 molar
ratio, as it does with egg-yolk (Ostrowski et al.,
1968) and egg-white riboflavin-binding protein
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Fig. 3. Sodium dodecyl sulphatelpolyacrylamide-gel electrophoresis ofthe immunoprecipitate
Liver slices (3 g) from chicks treated with oestrogen for 24h were incubated for 4h in the 3H-labelled amino acid mixture
as described in the Materials and Methods section. Samples (0.5 ml) of the homogenate were immunoprecipitated with
riboflavin-binding protein (RBP) antiserum (0.2ml) along with 50,g of pure protein. The immunoprecipitate was
washed and electrophoresed on sodium dodecyl sulphate/polyacrylamide gels. H and L refer to heavy-chain and
light-chain of immunoglobulin respectively.
(Rhodes et al., 1959). Furthermore, like yolk protein,
the protein lost its capacity to bind riboflavin on
freeze-drying, probably owing to aggregation
(Ostrowski et al., 1968).
Thus, clearly, theriboflavin-bindingprotein isolated
from sera of oestrogen-treated chicken was indis-
tinguishable from yolk riboflavin-binding protein in
terms ofmolecular size and functional characteristics,
in contrast with the major oestrogen-induced yolk
proteins, namely lipovitellin and phosvitin in
amphibia (Tata, 1976) and chicken (Gruber et al.,
1976) systems. Isolation of phosvitin directly from
the plasma by using lipase is apparently the result of
the susceptibility of vitellogenin to a proteolytic
contaminant of the lipase (Bergink et al., 1973).
Although we have taken care to minimize the degra-
dative processes by conducting the protein isolation
at 0-4°C, to substantiate our findings further the
nature of newly synthesized and secreted riboflavin-
binding protein in vitro was examined. Liver slices
(freed of blood) from oestrogen-treated birds were
incubated in vitro with 3H-labelled amino acids and
labelled protein in the cytosol and that secreted into
the medium was immunoprecipitated and analysed
by sodium dodecyl sulphate/polyacrylamide-gel
electrophoresis. Fig. 3 depicts the distribution of
radioactivity throughout the gel. Besides stainable
bands corresponding to light and heavy chains of
the immunoglobulin, the only other protein band,
accounting for almost all the radioactivity applied to
the gel, corresponded in size to yolk riboflavin-
binding protein. Identical patterns were obtained
with either the liver cytosol or the labelled protein
secreted into the medium, in agreement with quali-
tative observation made with the sera from
oestrogen-treated chicken.
Thus it appears that riboflavin-binding protein is
secreted by the liver into the systemic circulation and
taken up from there by the ovarian follicles without
any gross size and functional modification as for
retinol-binding protein of the same source (Heller,
1976). Further, the demonstration that the immuno-
logical activity resides entirely with only one mole-
cular species with full biological potency (riboflavin-
binding) supports our monitoring the protein in the
sera of oestrogen-treated birds by radioimmunoassay
(Murthy & Adiga, 1977a). This is particularly
pertinent, since immunological methods generally do
not distinguish between biologically active and
inactive or degraded molecules as exemplified by the
observations on growth-hormone concentrations in
acromegalic patients (Gordon et al., 1976) and
parathyroid hormone (Habener, 1976) in the
circulation. These data, however, do not preclude the
possibility that riboflavin-binding protein is, in fact,
synthesized intracellularly as a slightly larger
precursor and processed rapidly during translation
on polyribosomes and/or transit and packaging
through cisternae of endoplasmic reticulum and
Golgi bodies, as has been demonstrated for pro-
1978
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insulin-insulin conversion and a number of other
polypeptide hormones (Lernmark et al., 1976;
Campbell & Blobel, 1976) and serum albumin
(Judah et al., 1971). Further experiments with
purified mRNA specific for the protein and trans-
lation in a heterologous cell-free system should
clarify this possibility.
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